These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21192139)

  • 1. A double-blind, randomized trial of sertraline for alcohol dependence: moderation by age of onset [corrected] and 5-hydroxytryptamine transporter-linked promoter region genotype.
    Kranzler HR; Armeli S; Tennen H; Covault J; Feinn R; Arias AJ; Pettinati H; Oncken C
    J Clin Psychopharmacol; 2011 Feb; 31(1):22-30. PubMed ID: 21192139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-treatment outcomes in a double-blind, randomized trial of sertraline for alcohol dependence.
    Kranzler HR; Armeli S; Tennen H
    Alcohol Clin Exp Res; 2012 Apr; 36(4):739-44. PubMed ID: 21981418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HTTLPR genotype and daily negative mood moderate the effects of sertraline on drinking intensity.
    Kranzler HR; Armeli S; Tennen H; Covault J
    Addict Biol; 2013 Nov; 18(6):1024-31. PubMed ID: 23145795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A within-group design of nontreatment seeking 5-HTTLPR genotyped alcohol-dependent subjects receiving ondansetron and sertraline.
    Kenna GA; Zywiak WH; McGeary JE; Leggio L; McGeary C; Wang S; Grenga A; Swift RM
    Alcohol Clin Exp Res; 2009 Feb; 33(2):315-23. PubMed ID: 19032576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ondansetron reduces naturalistic drinking in nontreatment-seeking alcohol-dependent individuals with the LL 5'-HTTLPR genotype: a laboratory study.
    Kenna GA; Zywiak WH; Swift RM; McGeary JE; Clifford JS; Shoaff JR; Vuittonet C; Fricchione S; Brickley M; Beaucage K; Haass-Koffler CL; Leggio L
    Alcohol Clin Exp Res; 2014 Jun; 38(6):1567-74. PubMed ID: 24773166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of alcoholism subtypes as moderators of the response to sertraline treatment.
    Kranzler HR; Feinn R; Armeli S; Tennen H
    Alcohol Clin Exp Res; 2012 Mar; 36(3):509-16. PubMed ID: 21895712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ondansetron and sertraline may interact with 5-HTTLPR and DRD4 polymorphisms to reduce drinking in non-treatment seeking alcohol-dependent women: exploratory findings.
    Kenna GA; Zywiak WH; Swift RM; McGeary JE; Clifford JS; Shoaff JR; Fricchione S; Brickley M; Beaucage K; Haass-Koffler CL; Leggio L
    Alcohol; 2014 Sep; 48(6):515-22. PubMed ID: 25212749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of the 5-HTT gene-linked polymorphic region on emotional eating during stress exposure following tryptophan challenge.
    Markus CR; Verschoor E; Smeets T
    J Nutr Biochem; 2012 Apr; 23(4):410-6. PubMed ID: 21658929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype.
    Pettinati HM; Volpicelli JR; Kranzler HR; Luck G; Rukstalis MR; Cnaan A
    Alcohol Clin Exp Res; 2000 Jul; 24(7):1041-9. PubMed ID: 10924008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska natives and non-natives residing in rural settings: a randomized controlled trial.
    O'Malley SS; Robin RW; Levenson AL; GreyWolf I; Chance LE; Hodgkinson CA; Romano D; Robinson J; Meandzija B; Stillner V; Wu R; Goldman D
    Alcohol Clin Exp Res; 2008 Jul; 32(7):1271-83. PubMed ID: 18482155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between serotonin transporter gene promoter-region polymorphism and 4- and 12-week treatment response to sertraline in posttraumatic stress disorder.
    Mushtaq D; Ali A; Margoob MA; Murtaza I; Andrade C
    J Affect Disord; 2012 Feb; 136(3):955-62. PubMed ID: 21962566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in the gene encoding the serotonin transporter is associated with a measure of sociopathy in alcoholics.
    Herman AI; Conner TS; Anton RF; Gelernter J; Kranzler HR; Covault J
    Addict Biol; 2011 Jan; 16(1):124-32. PubMed ID: 20192950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: implications for the serotonergic system.
    Brunoni AR; Kemp AH; Shiozawa P; Cordeiro Q; Valiengo LC; Goulart AC; Coprerski B; Lotufo PA; Brunoni D; Perez AB; Fregni F; Benseñor IM
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1530-40. PubMed ID: 23615118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of 5-HTTLPR genotypes on inhibition of negative emotional information following acute stress exposure and tryptophan challenge.
    Markus CR; De Raedt R
    Neuropsychopharmacology; 2011 Mar; 36(4):819-26. PubMed ID: 21150915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of tri-allelic 5-HTTLPR polymorphisms in healthy subjects on mood and stress performance after tryptophan challenge.
    Markus CR; Firk C
    Neuropsychopharmacology; 2009 Dec; 34(13):2667-74. PubMed ID: 19675533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence.
    Pettinati HM; Oslin DW; Kampman KM; Dundon WD; Xie H; Gallis TL; Dackis CA; O'Brien CP
    Am J Psychiatry; 2010 Jun; 167(6):668-75. PubMed ID: 20231324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HTTLPR moderates naltrexone and psychosocial treatment responses in heavy drinking men who have sex with men.
    Chen AC; Davis CM; Kahler CW; Kuerbis AN; Covault J; Kranzler HR; Morgenstern J
    Alcohol Clin Exp Res; 2014 Sep; 38(9):2362-8. PubMed ID: 25070809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ondansetron in early- versus late-onset alcoholics: a prospective, open-label study.
    Kranzler HR; Pierucci-Lagha A; Feinn R; Hernandez-Avila C
    Alcohol Clin Exp Res; 2003 Jul; 27(7):1150-5. PubMed ID: 12878921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder.
    Brady KT; Sonne S; Anton RF; Randall CL; Back SE; Simpson K
    Alcohol Clin Exp Res; 2005 Mar; 29(3):395-401. PubMed ID: 15770115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking.
    Johnson BA; Ait-Daoud N; Seneviratne C; Roache JD; Javors MA; Wang XQ; Liu L; Penberthy JK; DiClemente CC; Li MD
    Am J Psychiatry; 2011 Mar; 168(3):265-75. PubMed ID: 21247998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.